Skip to content

Clinical trials

Phase 2 Hemoglobinuria, Paroxysmal trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemoglobinuria, Paroxysmal Phase: Phase 2 Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20051
20061
20072
20083
20092
20101
20122
20131
20151
20162
20176
20184
20194
20201
20215
20222
20234
20245
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Not yet recruiting7
Terminated7
Active, not recruiting6
Recruiting6
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.7
BioCryst Pharmaceuticals4
Novartis Pharmaceuticals3
NovelMed Therapeutics3
Regeneron Pharmaceuticals3
St. Jude Children's Research Hospital3
AKARI Therapeutics2
Apellis Pharmaceuticals, Inc.2
Chengdu Suncadia Medicine Co., Ltd.2
Fred Hutchinson Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemoglobinuria, Paroxysmal62
Anemia, Aplastic14
Myelodysplastic Syndromes9
Lymphoma, Non-Hodgkin8
Hodgkin Disease7
Leukemia7
Leukemia, Myeloid, Acute7
Precursor Cell Lymphoblastic Leukemia-Lymphoma7
Hemoglobinuria6
Multiple Myeloma6

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.